AstraZeneca’s $545m Deal with Pinetree for EGFR Degrader

Georgio Naffaa
Tagged:

Gowling WLG advised AstraZeneca on exclusive option and global license agreement with Pinetree Therapeutics.AstraZeneca has entered into an exclusive option and global license agreement with the…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Georgio Naffaa

…

This content is for Standard 1 Year members only.
Login Join Now